ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

Sondik Named Acting DCPC Deputy Director Sinks Leaving at End Of Month; Edwards Costlow Acting Ads

July 21, 1989

Manville Sues U.S. Over “Withheld” Wartime Data

July 22, 1983

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

Bypass Budget Going to White House Next Month Will Seek Optimal Funding for Cancer Program

August 22, 1980